Pharma Mar Statistics
Total Valuation
Pharma Mar has a market cap or net worth of EUR 1.62 billion. The enterprise value is 1.53 billion.
Market Cap | 1.62B |
Enterprise Value | 1.53B |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
Earnings Date | Jul 25, 2025 |
Ex-Dividend Date | Jun 25, 2025 |
Share Statistics
Pharma Mar has 17.57 million shares outstanding.
Current Share Class | 17.57M |
Shares Outstanding | 17.57M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 11.79% |
Owned by Institutions (%) | 8.86% |
Float | 12.74M |
Valuation Ratios
The trailing PE ratio is 81.26 and the forward PE ratio is 32.30. Pharma Mar's PEG ratio is 0.12.
PE Ratio | 81.26 |
Forward PE | 32.30 |
PS Ratio | 9.19 |
PB Ratio | 8.18 |
P/TBV Ratio | 8.22 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 0.12 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 110.22, with an EV/FCF ratio of -85.78.
EV / Earnings | 76.79 |
EV / Sales | 8.68 |
EV / EBITDA | 110.22 |
EV / EBIT | 198.68 |
EV / FCF | -85.78 |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.26.
Current Ratio | 2.97 |
Quick Ratio | 2.23 |
Debt / Equity | 0.26 |
Debt / EBITDA | 3.75 |
Debt / FCF | -2.92 |
Interest Coverage | 2.34 |
Financial Efficiency
Return on equity (ROE) is 10.19% and return on invested capital (ROIC) is 1.99%.
Return on Equity (ROE) | 10.19% |
Return on Assets (ROA) | 1.44% |
Return on Invested Capital (ROIC) | 1.99% |
Return on Capital Employed (ROCE) | 3.02% |
Revenue Per Employee | 351,494 |
Profits Per Employee | 39,752 |
Employee Count | 500 |
Asset Turnover | 0.53 |
Inventory Turnover | 0.21 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +140.68% in the last 52 weeks. The beta is -0.11, so Pharma Mar's price volatility has been lower than the market average.
Beta (5Y) | -0.11 |
52-Week Price Change | +140.68% |
50-Day Moving Average | 79.60 |
200-Day Moving Average | 74.51 |
Relative Strength Index (RSI) | 67.48 |
Average Volume (20 Days) | 52,139 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Pharma Mar had revenue of EUR 175.75 million and earned 19.88 million in profits.
Revenue | 175.75M |
Gross Profit | 165.93M |
Operating Income | 7.68M |
Pretax Income | 10.85M |
Net Income | 19.88M |
EBITDA | 11.73M |
EBIT | 7.68M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 140.85 million in cash and 51.94 million in debt, giving a net cash position of 88.91 million or 5.06 per share.
Cash & Cash Equivalents | 140.85M |
Total Debt | 51.94M |
Net Cash | 88.91M |
Net Cash Per Share | 5.06 |
Equity (Book Value) | 197.47M |
Book Value Per Share | n/a |
Working Capital | 156.52M |
Cash Flow
In the last 12 months, operating cash flow was -9.56 million and capital expenditures -8.23 million, giving a free cash flow of -17.79 million.
Operating Cash Flow | -9.56M |
Capital Expenditures | -8.23M |
Free Cash Flow | -17.79M |
FCF Per Share | -1.01 |
Margins
Gross margin is 94.41%, with operating and profit margins of 4.37% and 11.31%.
Gross Margin | 94.41% |
Operating Margin | 4.37% |
Pretax Margin | 6.17% |
Profit Margin | 11.31% |
EBITDA Margin | 6.67% |
EBIT Margin | 4.37% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.80, which amounts to a dividend yield of 0.88%.
Dividend Per Share | 0.80 |
Dividend Yield | 0.88% |
Dividend Growth (YoY) | 23.08% |
Years of Dividend Growth | 1 |
Payout Ratio | 57.46% |
Buyback Yield | n/a |
Shareholder Yield | 0.88% |
Earnings Yield | 1.23% |
FCF Yield | -1.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 22, 2020. It was a reverse split with a ratio of 0.0833333333.
Last Split Date | Jul 22, 2020 |
Split Type | Reverse |
Split Ratio | 0.0833333333 |
Scores
Pharma Mar has an Altman Z-Score of 6.33.
Altman Z-Score | 6.33 |
Piotroski F-Score | n/a |